Cat: IPD-X23987

Recombinant Mouse FSTL3 Protein (HEK293),His

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • Gene name

    FSTL3

  • 简介

    In its secreted form, the FSTL3 protein acts as a binder and antagonist to TGF-β family members, inhibiting cell signaling induced by activin A, activin B, BMP2, and MSTN. It plays a role in bone formation, inhibition of osteoclast differentiation, hematopoiesis, and enhanced hematopoietic progenitor cell adhesion. FSTL3 Protein, Mouse (HEK293, His) is the recombinant mouse-derived FSTL3 protein, expressed by HEK293 , with C-His labeled tag.

  • Application

    SPRMSTBLIITCELISACELL ASSAYDRUG SCREENING

  • Biological Activity

    1.Immobilized Human Activin A, No Tag at 0.2 μg/mL (100 μl/well) on the plate. Dose response curve for Mouse FSTL3, His Tag with the EC50 of >20.1 ng/mL determined by ELISA. 2.Measured by its binding ability in a functional ELISA. Immobilized mouse FLRG-His at 10 μg/mL (100 μL/well) can bind biotinylated mouse INHBA, the ED50 for this effect is 21.37 ng/mL. Measured by its binding ability in a functional ELISA. Immobilized mouse FLRG-His at 10 μg/mL (100 μL/well) can bind biotinylated mouse INHBA,The ED50 for this effect is 21.37 ng/mL.

  • Alternative Names

    Follistatin-related protein 3; Follistatin-like protein 3; FLRG

  • Species

    Mouse

  • Source

    HEK293

  • Tag

    C-His

  • Purity

    Greater than 95% as determined by SDS-PAGE.

  • Uniprot

    Q9EQC7

  • Expression Region

    V24-V256

  • AA Sequence

    VMGSEDSVPGGVCWLQQGREATCSLVLKTRVSREECCASGNINTAWSNFTHPGNKISLLGFLGLVHCLPCKDSCDGVECGPGKACRMLGGRPHCECVPNCEGLPAGFQVCGSDGATYRDECELRTARCRGHPDLRVMYRGRCQKSCAQVVCPRPQSCLVDQTGSAHCVVCRAAPCPVPSNPGQELCGNNNVTYISSCHLRQATCFLGRSIGVRHPGICTGGPKVPAEEEENFV

  • Protein Length

    Full Length of Mature Protein

  • Molecular Weight

    35-40 kDa.

  • Endotoxin

    < 1.0 EU per μg protein as determined by the LAL method.

  • Form

    Freeze-dried powder

  • Buffer formulation

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • Reconstitution

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • Customization

    Site-directed mutagenesis Custom tag design Custom buffer formulation Custom full-length protein production

  • Stability Test

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • Storage & Shelf Life

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • Shipping

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

FSTL3 (Follistatin-like 3) is a secreted glycoprotein belonging to the follistatin family, known for its role in modulating various biological processes, including inflammation, tissue repair, and metabolic regulation. Increased interest in FSTL3 has emerged due to its involvement in several pathophysiological conditions, such as obesity, diabetes, and cardiovascular diseases. Research indicates that FSTL3 may play a protective role against the progression of these diseases by influencing insulin sensitivity and inflammatory responses. Consequently, the recombinant production of FSTL3 protein has gained momentum, allowing for in-depth studies of its biological functions and potential therapeutic applications. Recombinant forms facilitate the investigation of FSTL3's mechanism of action, as well as its role in cellular signaling pathways and interactions with other proteins. The ability to produce FSTL3 in sufficient quantities also paves the way for drug development and biomarker discovery, with implications for improving patient outcomes in metabolic and inflammatory diseases. Overall, the exploration of FSTL3 as a recombinant protein is essential for understanding its roles in health and disease, and it holds promise for innovations in clinical treatments.

E-mail

sales@ipodix.com

Sales

+1 2092920560


Contact us via WhatsApp

IPODIX Biotech Inc

2108 N ST, STE N
Sacramento, CA 95816, USA

For Product Information and Orders

sales@ipodix.com

For Business Collaboration

sales@ipodix.com

For CRO Services

sales@ipodix.com

For Technical Support

sales@ipodix.com
  • 50000+

    Recombinant Proteins

  • 100+

    Researchers

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US